WATCH PIMCO- They have the exposure in Russia and they could be the tipping point to our next market decline. PIMCO seems to have acted boldly and stupidly betting on Russia even after the war. They have various SWAPS that need to be cashed out. Will PIMCO open up a Russian bank account and do all these Russian tricks to get paid? Or will Biden and Co slam the window shut?
Raves. What is their effect on the economy? I wonder. I fell prey to this attractive version of nightclubbing... a rave in an abandoned building was the thing to do in the 90's. But what of all these kids now grown up? How can they run things?
STOCK SPOTLIGHT LDOS. This may finally be the breakout that has taken 3 years in the making. Contract after contract and this stock never leaves $100... But maybe this one is just too big! Leidos unit awarded two prime contracts worth up to $1.7B 08:05 LDOS
Abbott announces FDA cleared its FreeStyle Libre 3 system 08:03 Dish jumps as Truist upgrades, sees 150% upside on potential to be 'nationwide carrier'
We made a little trade on Abbot to $114. // Might be time to get back in! (ABT) NYSE - NYSE Delayed Price. 116.69+1.82(+1.58%) At close: May 27 04:03PM EDT 116.39-0.30(-0.26%)<------------ VAN! Pre-Market:08:25AM EDT Abbott's Libre 3 approval came slightly ahead of expectations, says BofA 08:13 ABT, DXCM After the FDA posted on Monday its approval for Abbott's (ABT) FreeStyle Libre 3 Continuous Glucose Monitoring, or CGM, system and the company affirmed the news, BofA analyst Travis Steed said the approval came slightly ahead of expectations and the label came in "as expected." Libre 3 is not yet able to operate an automated pump like Control-IQ given the warning that taking vitamin C supplements could falsely raise sensor glucose readings, but a new smaller trial is already underway to remove this warning and Abbott is hopeful to have this contraindication resolved around the end of this year, said Steed, who adds that he views the approval as a good sign the FDA is back to focusing on diabetes approvals and thinks DexCom's (DXCM) G7 approval is "likely in the very near term." Steed maintains a Buy rating and $140 price target on Abbott shares. Imax announces best ever global four-day Memorial Day Weekend opening 08:12 IMAX, PARA Imax (IMAX) soared to its best global four-day Memorial Day Weekend opening ever with the $32.5M debut of Paramount Pictures' (PARA) "Top Gun: Maverick", starring cinema icon Tom Cruise. Crushing industry expectations, the aerial actioner also scored the biggest domestic four-day Memorial Day Weekend opening ever in IMAX with $21M, good for a stunning 14% of the overall North American box office.